Navigation Links
China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
Date:5/29/2008

TAIAN CITY, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("China" or the "PRC"), today announced that the Company has been approved by the Chinese State Food and Drug Administration (the "SFDA") to commence the production of Human Albumin 12.5g/vial (25%, 50 ml).

Human Albumin 12.5g/vial (25%, 50 ml), contains the highest concentration and delivers the highest dosage of the Human Albumin family products in Mainland China, and has a better effect on the clinical application for ascites due to liver cirrhosis, external injuries, hydrocephalus due to cerebral hemorrhage, serious hypoproteinemia, and other major diseases. With this approval, CBP is now one of the few producers offering the widest range of Human Albumin products available in China.

"We are pleased to receive approval from the SFDA to produce this concentration and dosage of Human Albumin," said Mr. Chaoming Zhao, CFO of China Biologic. "The approval represents a significant milestone for our Company."

The Company has already commenced the production and marketing of this new product.

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention diseases.

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiary companies. All
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)...CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-First...iringtheassetsofHylandSeeds,adivisionofThompsonsLi...llfurtherexpandDowAgroSciences,currentseedsbusines...x(TM) in 2010 andDowAgroSciencesHerbicideToleran...isexpectedinthenearfuture. ,, "Thisacquisitionb...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...y announces implementation of Kingdee enterprise a...perations , , TUSTIN, Calif., Jan. 29 AMDL, Inc.... pharmaceutical company with operations in China a...ate-of-the-art, westernized enterprise accounting ..., , Developed by China-based Kingdee Internatio...
...ies to Collaborate on Next Generation Laboratory I...ss., Jan. 29 Cantimer, Inc. and Advanced Instrume...struments Inc. has made a $1 Million equity invest...nced their intention to collaborate on the develop... for osmolality measurement, incorporating Cantime...
...y will proceed with clinical trials of first-in-cl...SHORES, Calif., Jan. 29 Omnitura Therapeutics Inc... into a $24 million private placement agreement wi...ancing, investments will be made in three tranches...ore December 31, 2009 and $8 million before Decemb...
Other Biology Technology:AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 3AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 4Advanced Instruments Makes Strategic Investment in Cantimer, Inc. 2Omnitura Therapeutics Announces Private Placement Financing 2
(Date:11/23/2009)..., Mass. November 23, 2009 Applied mathematicians...osta lancifolia ), a characteristic long leaf with...ipples along the edges. The simple cause of the li...om bending during differential growthwas revealed ...oam ribbons. , Haiyi Liang, a postdoctoral stude...
(Date:11/23/2009).... -- More than 160 participants gathered this week...TURES INITIATIVE conference. This year,s topic, "S...gineers, and medical researchers to explore the en...ng the emerging field of synthetic biology. , Bo... Princeton University and this year,s conference c...
(Date:11/23/2009)...- The only swine vaccine available for the H1N1 vi...ed with the virus. The vaccination marks the first...sed with the pandemic flu., Iowa State Universit...loped the vaccine this summer and has been shippin...sas and Illinois for several weeks., The latest ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 1Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 3Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 1Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 2Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4
...University at Buffalo and the University of Pennsy...acellular events, both stimulated by the same cell...als. , The broad implication of the findings may a...t sub-cellular underpinnings of mammalian behavior...vergent Behavioral Roles of Angiotensin Receptor I...
...k-footed geese (Anser brachyrhynchus) prepare for ...n the Arctic, ecologists are warning that the esca...hreatening the birds, survival. Writing in the new... of Applied Ecology, Professor Marcel Klaassen of ...ernational action is urgently required. , Farmers ...
...x linking artificial sweeteners such as saccharin ...es on a sweet taste has guided researchers to an i...taste. , Reporting in an advance online publicat... Senses Center describe how certain artificial swe...-K, paradoxically inhibit sweet taste at high conc...
Other Biology News:Manipulating single cell receptor alters animal behavior 2Manipulating single cell receptor alters animal behavior 3Spring migration of pink-footed geese under threat 2Sweet 'water taste' paradoxically predicts sweet taste inhibitors 2
Disposable Cuvettes, 1,000/pkg from Promega
luciferase Assay Kit, Bright-Glo from Promega
... ideal for developing single and multi-analyte ass... contains the new, improved, and user friendly IS ... specific templates for commercial or home-made mu...hing and data regression capabilities; the interna...
...ified USDA Research Registered OLAW Assured AAALAC...ing AALAS Certified Technicians Documentation G...on Request Focus CRP is your one stop shopping p... We offer free project consultation, free peptide...
Biology Products: